Robert C. Sterner

Oncology · 2021

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Robert C. Sterner trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Michel Sadelain
  2. R. Brentjens

Papers from Robert C. Sterner's perspective

Ordered by how strongly the researchers Robert C. Sterner trusts endorse each paper. Same corpus, a different order for every researcher.

  1. The basic principles of chimeric antigen receptor (CAR) design (Cancer Discovery)
  2. Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia (New England Journal of Medicine)
  3. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma (New England Journal of Medicine)
  4. CAR T cell immunotherapy for human cancer (Science)
  5. T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia (Science Translational Medicine)
  6. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia (Science Translational Medicine)
  7. Endothelial activation and blood-brain barrier disruption in neurotoxicity after adoptive immunotherapy with CD19 CAR-T cells (Cancer Discovery)
  8. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia (New England Journal of Medicine)
  9. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia (New England Journal of Medicine)
  10. Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells (Nature Medicine)

Their papers